The progesterone receptor (PR) controls various physiological processes, including the female reproductive system, and nonsteroidal PR ligands are considered to be drug candidates for treatment of various diseases without significant adverse effects. Here, we designed and synthesized m-carborane-based secondary alcohols and investigated their PR-ligand activity. All the synthesized alcohols exhibited PR-antagonistic activity at subnanomolar concentration. Among them, alcohols having a small alkyl side chain and a 4-cyanophenyl group also exhibited PR-agonistic activity in a relatively high concentration range. Optical resolution of secondary alcohols having a methyl side chain was performed, and the PR-ligand activity and PR-binding affinity of the purified enantiomers were examined. The chirality of the secondary alcohol appears to have a more significant influence on PR-agonistic activity than on antagonistic activity.Key words progesterone receptor; antagonist; carborane; chirality; lipase The progesterone receptor (PR) is a member of the nuclear receptor superfamily and plays important roles in many physiological processes, especially in the female reproductive system, via ligand-dependent transcriptional activation of various target genes.1) Progesterone (1, Fig. 1) is an endogenous PR agonist that regulates many physiological processes, [2][3][4][5] including uterine cell proliferation/differentiation, the ovulation cycle, and implantation. In addition, 1 modulates the activities of major physiological systems such as the cardiovascular , 6) immune, 7) and nervous systems. 8) Several synthetic PR agonists and antagonists have been developed for clinical use [9][10][11] in contraception, hormone replacement therapy, treatment of gynecological disorders, and abortion. For example, synthetic PR antagonist mifepristone (2, Fig. 1) is a representative abortifacient.12) It has also been suggested that 2 might be effective in the treatment of endometriosis, 13) uterine leiomyoma, 14) and breast cancer. 15,16) However, all PR ligands currently in clinical use, including 2, are steroid derivatives, and may have significant adverse effects because of their cross-activity toward other steroid hormone receptors. 17) In order to avoid these adverse effects, non-steroidal PR ligands are required, and indeed, several non-steroidal ligands have been developed, such as tanaproget (3) 18) and a sulfonamide derivative (4) 19) (Fig. 1).
Results and DiscussionWe have reported non-steroidal PR ligands bearing boroncluster compounds (carborane) as their hydrophobic core structures. [20][21][22] Carboranes, more precisely dicarba-closododecaboranes (C 2 B 10 H 12 ), are carbon-containing boron clusters with icosahedral cage structure; there are three isomers depending upon the position of the two carbon atoms, that is, ortho-, meta-, and para-carborane [23][24][25] (Fig. 2a). Carboranes have high thermal and chemical stability, and exceptionally high hydrophobicity, [26][27][28][29] and we have applied them as hydrophobic core ...